An overview of regular dialysis treatment in Japan (as of 31 December 2007)

Shigeru Nakai, Ikuto Masakane, Takashi Shigematsu, Takayuki Hamano, Kunihiro Yamagata, Yuuzou Watanabe, Noritomo Itami, Satoshi Ogata, Naoki Kimata, Toshio Shinoda, Tetsuo Syouji, Kazuyuki Suzuki, Masatomo Taniguchi, Kenji Tsuchida, Hidetomo Nakamoto, Shinichi Nishi, Hiroshi Nishi, Seiji Hashimoto, Takeshi Hasegawa, Norio HanafusaNaohiko Fujii, Seiji Marubayashi, Osamu Morita, Kenji Wakai, Atsushi Wada, Kunitoshi Iseki, Yoshiharu Tsubakihara

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

A nationwide statistical survey of 4098 dialysis facilities was conducted at the end of 2007, and 4052 facilities (98.88%) participated. The number of patients undergoing dialysis at the end of 2007 was determined to be 275 242, an increase of 10 769 patients (4.1%) compared with that at the end of 2006.The number of dialysis patients per million at the end of 2007 was 2154. The crude death rate of dialysis patients at the end of 2007 from the end of 2006 was 9.4%. The mean age of new patients begun on dialysis was 66.8 years and the mean age of the entire dialysis patient population was 64.9 years. For the primary diseases of new patients begun on dialysis, the percentages of patients with diabetic nephropathy and chronic glomerulonephritis were 43.4% and 23.8%, respectively. The percentages of facilities that achieved the control standard of endotoxin concentration in the dialysate solution of <0.05 EU/mL and those that achieved a bacterial count of <100 cfu/mL in the dialysate solution, as specified by the Japanese Society for Dialysis Therapy, were 93.6% and 97.4%, respectively. The percentage of patients positive for the hepatitis C virus antibody among the entire dialysis population significantly decreased from 15.95% at the end of 1999 to 9.83% at the end of 2007. The mean hemoglobin concentration in all the dialysis patients at the end of 2007 was 10.27 (±1.32, SD) g/dL, which has scarcely changed over the last three years. The numbers of male and female patients with a history of hip fracture were 142.9 and 339.0 per 10 000 dialysis patients, respectively, showing an extremely high prevalence among female patients. A history of hip fracture correlates with a low body mass index, serum albumin concentration, and a history of diabetes. The serum creatinine level of patients upon introduction to dialysis was 8.34 (±3.55) mg/dL, and the estimated glomerular filtration rate was 5.43 (±3.43) mL/min/1.73 m2 for the patients who were newly begun on dialysis in 2007.

Original languageEnglish (US)
Pages (from-to)457-504
Number of pages48
JournalTherapeutic Apheresis and Dialysis
Volume13
Issue number6
DOIs
StatePublished - Dec 2009

Fingerprint

Dialysis
Japan
Therapeutics
Dialysis Solutions
Hip Fractures
Facility Regulation and Control
Hepatitis C Antibodies
Bacterial Load
Diabetic Nephropathies
Glomerulonephritis
Glomerular Filtration Rate
Endotoxins
Serum Albumin
Population
Creatinine
Hemoglobins
Body Mass Index

Keywords

  • Clinical condition
  • Dialysis patient population
  • Endotoxin concentration
  • History of fracture
  • Survey
  • Survival rate

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Cite this

Nakai, S., Masakane, I., Shigematsu, T., Hamano, T., Yamagata, K., Watanabe, Y., ... Tsubakihara, Y. (2009). An overview of regular dialysis treatment in Japan (as of 31 December 2007). Therapeutic Apheresis and Dialysis, 13(6), 457-504. https://doi.org/10.1111/j.1744-9987.2009.00789.x

An overview of regular dialysis treatment in Japan (as of 31 December 2007). / Nakai, Shigeru; Masakane, Ikuto; Shigematsu, Takashi; Hamano, Takayuki; Yamagata, Kunihiro; Watanabe, Yuuzou; Itami, Noritomo; Ogata, Satoshi; Kimata, Naoki; Shinoda, Toshio; Syouji, Tetsuo; Suzuki, Kazuyuki; Taniguchi, Masatomo; Tsuchida, Kenji; Nakamoto, Hidetomo; Nishi, Shinichi; Nishi, Hiroshi; Hashimoto, Seiji; Hasegawa, Takeshi; Hanafusa, Norio; Fujii, Naohiko; Marubayashi, Seiji; Morita, Osamu; Wakai, Kenji; Wada, Atsushi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu.

In: Therapeutic Apheresis and Dialysis, Vol. 13, No. 6, 12.2009, p. 457-504.

Research output: Contribution to journalArticle

Nakai, S, Masakane, I, Shigematsu, T, Hamano, T, Yamagata, K, Watanabe, Y, Itami, N, Ogata, S, Kimata, N, Shinoda, T, Syouji, T, Suzuki, K, Taniguchi, M, Tsuchida, K, Nakamoto, H, Nishi, S, Nishi, H, Hashimoto, S, Hasegawa, T, Hanafusa, N, Fujii, N, Marubayashi, S, Morita, O, Wakai, K, Wada, A, Iseki, K & Tsubakihara, Y 2009, 'An overview of regular dialysis treatment in Japan (as of 31 December 2007)', Therapeutic Apheresis and Dialysis, vol. 13, no. 6, pp. 457-504. https://doi.org/10.1111/j.1744-9987.2009.00789.x
Nakai, Shigeru ; Masakane, Ikuto ; Shigematsu, Takashi ; Hamano, Takayuki ; Yamagata, Kunihiro ; Watanabe, Yuuzou ; Itami, Noritomo ; Ogata, Satoshi ; Kimata, Naoki ; Shinoda, Toshio ; Syouji, Tetsuo ; Suzuki, Kazuyuki ; Taniguchi, Masatomo ; Tsuchida, Kenji ; Nakamoto, Hidetomo ; Nishi, Shinichi ; Nishi, Hiroshi ; Hashimoto, Seiji ; Hasegawa, Takeshi ; Hanafusa, Norio ; Fujii, Naohiko ; Marubayashi, Seiji ; Morita, Osamu ; Wakai, Kenji ; Wada, Atsushi ; Iseki, Kunitoshi ; Tsubakihara, Yoshiharu. / An overview of regular dialysis treatment in Japan (as of 31 December 2007). In: Therapeutic Apheresis and Dialysis. 2009 ; Vol. 13, No. 6. pp. 457-504.
@article{b1abb388c5ed4c5a9ad6a6efc666e25f,
title = "An overview of regular dialysis treatment in Japan (as of 31 December 2007)",
abstract = "A nationwide statistical survey of 4098 dialysis facilities was conducted at the end of 2007, and 4052 facilities (98.88{\%}) participated. The number of patients undergoing dialysis at the end of 2007 was determined to be 275 242, an increase of 10 769 patients (4.1{\%}) compared with that at the end of 2006.The number of dialysis patients per million at the end of 2007 was 2154. The crude death rate of dialysis patients at the end of 2007 from the end of 2006 was 9.4{\%}. The mean age of new patients begun on dialysis was 66.8 years and the mean age of the entire dialysis patient population was 64.9 years. For the primary diseases of new patients begun on dialysis, the percentages of patients with diabetic nephropathy and chronic glomerulonephritis were 43.4{\%} and 23.8{\%}, respectively. The percentages of facilities that achieved the control standard of endotoxin concentration in the dialysate solution of <0.05 EU/mL and those that achieved a bacterial count of <100 cfu/mL in the dialysate solution, as specified by the Japanese Society for Dialysis Therapy, were 93.6{\%} and 97.4{\%}, respectively. The percentage of patients positive for the hepatitis C virus antibody among the entire dialysis population significantly decreased from 15.95{\%} at the end of 1999 to 9.83{\%} at the end of 2007. The mean hemoglobin concentration in all the dialysis patients at the end of 2007 was 10.27 (±1.32, SD) g/dL, which has scarcely changed over the last three years. The numbers of male and female patients with a history of hip fracture were 142.9 and 339.0 per 10 000 dialysis patients, respectively, showing an extremely high prevalence among female patients. A history of hip fracture correlates with a low body mass index, serum albumin concentration, and a history of diabetes. The serum creatinine level of patients upon introduction to dialysis was 8.34 (±3.55) mg/dL, and the estimated glomerular filtration rate was 5.43 (±3.43) mL/min/1.73 m2 for the patients who were newly begun on dialysis in 2007.",
keywords = "Clinical condition, Dialysis patient population, Endotoxin concentration, History of fracture, Survey, Survival rate",
author = "Shigeru Nakai and Ikuto Masakane and Takashi Shigematsu and Takayuki Hamano and Kunihiro Yamagata and Yuuzou Watanabe and Noritomo Itami and Satoshi Ogata and Naoki Kimata and Toshio Shinoda and Tetsuo Syouji and Kazuyuki Suzuki and Masatomo Taniguchi and Kenji Tsuchida and Hidetomo Nakamoto and Shinichi Nishi and Hiroshi Nishi and Seiji Hashimoto and Takeshi Hasegawa and Norio Hanafusa and Naohiko Fujii and Seiji Marubayashi and Osamu Morita and Kenji Wakai and Atsushi Wada and Kunitoshi Iseki and Yoshiharu Tsubakihara",
year = "2009",
month = "12",
doi = "10.1111/j.1744-9987.2009.00789.x",
language = "English (US)",
volume = "13",
pages = "457--504",
journal = "Therapeutic Apheresis and Dialysis",
issn = "1744-9979",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - An overview of regular dialysis treatment in Japan (as of 31 December 2007)

AU - Nakai, Shigeru

AU - Masakane, Ikuto

AU - Shigematsu, Takashi

AU - Hamano, Takayuki

AU - Yamagata, Kunihiro

AU - Watanabe, Yuuzou

AU - Itami, Noritomo

AU - Ogata, Satoshi

AU - Kimata, Naoki

AU - Shinoda, Toshio

AU - Syouji, Tetsuo

AU - Suzuki, Kazuyuki

AU - Taniguchi, Masatomo

AU - Tsuchida, Kenji

AU - Nakamoto, Hidetomo

AU - Nishi, Shinichi

AU - Nishi, Hiroshi

AU - Hashimoto, Seiji

AU - Hasegawa, Takeshi

AU - Hanafusa, Norio

AU - Fujii, Naohiko

AU - Marubayashi, Seiji

AU - Morita, Osamu

AU - Wakai, Kenji

AU - Wada, Atsushi

AU - Iseki, Kunitoshi

AU - Tsubakihara, Yoshiharu

PY - 2009/12

Y1 - 2009/12

N2 - A nationwide statistical survey of 4098 dialysis facilities was conducted at the end of 2007, and 4052 facilities (98.88%) participated. The number of patients undergoing dialysis at the end of 2007 was determined to be 275 242, an increase of 10 769 patients (4.1%) compared with that at the end of 2006.The number of dialysis patients per million at the end of 2007 was 2154. The crude death rate of dialysis patients at the end of 2007 from the end of 2006 was 9.4%. The mean age of new patients begun on dialysis was 66.8 years and the mean age of the entire dialysis patient population was 64.9 years. For the primary diseases of new patients begun on dialysis, the percentages of patients with diabetic nephropathy and chronic glomerulonephritis were 43.4% and 23.8%, respectively. The percentages of facilities that achieved the control standard of endotoxin concentration in the dialysate solution of <0.05 EU/mL and those that achieved a bacterial count of <100 cfu/mL in the dialysate solution, as specified by the Japanese Society for Dialysis Therapy, were 93.6% and 97.4%, respectively. The percentage of patients positive for the hepatitis C virus antibody among the entire dialysis population significantly decreased from 15.95% at the end of 1999 to 9.83% at the end of 2007. The mean hemoglobin concentration in all the dialysis patients at the end of 2007 was 10.27 (±1.32, SD) g/dL, which has scarcely changed over the last three years. The numbers of male and female patients with a history of hip fracture were 142.9 and 339.0 per 10 000 dialysis patients, respectively, showing an extremely high prevalence among female patients. A history of hip fracture correlates with a low body mass index, serum albumin concentration, and a history of diabetes. The serum creatinine level of patients upon introduction to dialysis was 8.34 (±3.55) mg/dL, and the estimated glomerular filtration rate was 5.43 (±3.43) mL/min/1.73 m2 for the patients who were newly begun on dialysis in 2007.

AB - A nationwide statistical survey of 4098 dialysis facilities was conducted at the end of 2007, and 4052 facilities (98.88%) participated. The number of patients undergoing dialysis at the end of 2007 was determined to be 275 242, an increase of 10 769 patients (4.1%) compared with that at the end of 2006.The number of dialysis patients per million at the end of 2007 was 2154. The crude death rate of dialysis patients at the end of 2007 from the end of 2006 was 9.4%. The mean age of new patients begun on dialysis was 66.8 years and the mean age of the entire dialysis patient population was 64.9 years. For the primary diseases of new patients begun on dialysis, the percentages of patients with diabetic nephropathy and chronic glomerulonephritis were 43.4% and 23.8%, respectively. The percentages of facilities that achieved the control standard of endotoxin concentration in the dialysate solution of <0.05 EU/mL and those that achieved a bacterial count of <100 cfu/mL in the dialysate solution, as specified by the Japanese Society for Dialysis Therapy, were 93.6% and 97.4%, respectively. The percentage of patients positive for the hepatitis C virus antibody among the entire dialysis population significantly decreased from 15.95% at the end of 1999 to 9.83% at the end of 2007. The mean hemoglobin concentration in all the dialysis patients at the end of 2007 was 10.27 (±1.32, SD) g/dL, which has scarcely changed over the last three years. The numbers of male and female patients with a history of hip fracture were 142.9 and 339.0 per 10 000 dialysis patients, respectively, showing an extremely high prevalence among female patients. A history of hip fracture correlates with a low body mass index, serum albumin concentration, and a history of diabetes. The serum creatinine level of patients upon introduction to dialysis was 8.34 (±3.55) mg/dL, and the estimated glomerular filtration rate was 5.43 (±3.43) mL/min/1.73 m2 for the patients who were newly begun on dialysis in 2007.

KW - Clinical condition

KW - Dialysis patient population

KW - Endotoxin concentration

KW - History of fracture

KW - Survey

KW - Survival rate

UR - http://www.scopus.com/inward/record.url?scp=71949117280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71949117280&partnerID=8YFLogxK

U2 - 10.1111/j.1744-9987.2009.00789.x

DO - 10.1111/j.1744-9987.2009.00789.x

M3 - Article

C2 - 19954472

AN - SCOPUS:71949117280

VL - 13

SP - 457

EP - 504

JO - Therapeutic Apheresis and Dialysis

JF - Therapeutic Apheresis and Dialysis

SN - 1744-9979

IS - 6

ER -